Craniofacial Muscles

50 L.K. McLoon et al.
Tajbakhsh S, Rocancout D, Cossu G, Buckingham M (1997) Rede fi ning the genetic hierarchies
controlling skeletal myogenesis: Pax-3 and myf-5 act upstream of MyoD. Cell 89:127–138
Toniolo L, Maccatrozzo L, Patruno M, Pavan E, Caliario F, Rossi R, Rinaldi C, Canepari M,
Reggiani C, Mascarello F (2007) Fiber types in canine muscles: myosin isoform expression
and functional characterization. Am J Physiol Cell Physiol 292:1915–1926
Ugalde I, Christiansen SP, McLoon LK (2005) Botulinum toxin treatment of extraocular muscles
in rabbits results in increased myo fi ber remodeling. Invest Ophthalmol Vis Sci 46:4114–4120
Wasicky R, Ziya-Ghazvini F, Blumer R, Lukas JR, Mayr R (2000) Muscle fi ber types of human
extraocular muscles: a histochemical and immunohistochemical study. Invest Ophthalmol Vis
Sci 41:980–990
Wieczorek DF, Periasamy M, Butler-Browne GS, Whalen RG, Nadal-Ginard B (1985)
Co-expression of multiple myosin heavy chain genes, in addition to a tissue-speci fi c one, in
extraocular musculature. J Cell Biol 101:618–629
Zacharias AL, Lewandoski M, Rudnicki MA, Gage PJ (2011) Pitx2 is an upstream activator of
extraocular myogenesis and survival. Dev Biol 349:395–405
Zeiger U, Mitchell CH, Khurana TS (2010) Superior calcium homeostasis of extraocular muscles.
Exp Eye Res 91:613–622
Zhou Y, Cheng G, Dieter L, Hjalt TA, Andrade FH, Stahl JS, Kaminski HJ (2009) An altered phenotype
in a conditional knockout of Pitx2 in extraocular muscle. Invest Ophthalmol Vis Sci
50:4531–4541
Zhou Y, Liu D, Kaminski HJ (2010) Myosin heavy chain expression in mouse extraocular muscle:
more complex than expected. Invest Ophthalmol Vis Sci 51:6355–6363